The expression of CD200R1 decreases in various neuroinflammatory diseases such as AD, MS (15, 43) and in experimental disease models such as EAE, EAU, SCI, and PD (16, 18, 19, 44). The gene discussed is CD200R1; the disease is myeloid sarcoma.